<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-07T01:11:40+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>专家谈新修订《药品质量抽查检验管理办法》</title>
    <updated>2020-11-06T19:05:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/I0STYm6c2nVr3N-hFA8Dmg</id>
    <link href="https://mp.weixin.qq.com/s/I0STYm6c2nVr3N-hFA8Dmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有机合成经验总结，细节决定效率</title>
    <updated>2020-11-06T19:05:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/O3GuwtV_BOk_QyeZQ1wESQ</id>
    <link href="https://mp.weixin.qq.com/s/O3GuwtV_BOk_QyeZQ1wESQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>质量风险管理-PPT</title>
    <updated>2020-11-06T19:05:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/v5HKwIbJkAaBkkmg58K2uw</id>
    <link href="https://mp.weixin.qq.com/s/v5HKwIbJkAaBkkmg58K2uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国CAR-T临概况及中美对比</title>
    <updated>2020-11-05T19:15:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/3UCv_3cz6uwWlhY8CLd1kA</id>
    <link href="https://mp.weixin.qq.com/s/3UCv_3cz6uwWlhY8CLd1kA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥司他韦竞争激烈，原料药需求上涨</title>
    <updated>2020-11-05T19:15:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/uxPq-cLFat4yC7ZE2xkvHA</id>
    <link href="https://mp.weixin.qq.com/s/uxPq-cLFat4yC7ZE2xkvHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规角度对生物类似药审评审批的考量</title>
    <updated>2020-11-05T19:15:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/rN4dxsPpWailiIm5ElDFpw</id>
    <link href="https://mp.weixin.qq.com/s/rN4dxsPpWailiIm5ElDFpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肺癌靶向治疗黄金时代！十一款免费新药为晚期患者再续生命</title>
    <updated>2020-11-04T19:31:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/j4CLuaIO27V1IQmhB1Q8iQ</id>
    <link href="https://mp.weixin.qq.com/s/j4CLuaIO27V1IQmhB1Q8iQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！CDE发布发布《中药新药研究各阶段药学研究技术指导原则（试行）》</title>
    <updated>2020-11-04T19:31:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Jj0-_OHTGVyGsGU1TAI2hw</id>
    <link href="https://mp.weixin.qq.com/s/Jj0-_OHTGVyGsGU1TAI2hw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！中国晚期乳腺癌规范诊疗指南（2020版）</title>
    <updated>2020-11-04T19:31:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Op8U7v2PbDe_INC33_K3Eg</id>
    <link href="https://mp.weixin.qq.com/s/Op8U7v2PbDe_INC33_K3Eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂工艺研究和工艺验证</title>
    <updated>2020-11-03T19:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/VBdiyrpQA2yDv6ZDknpmuA</id>
    <link href="https://mp.weixin.qq.com/s/VBdiyrpQA2yDv6ZDknpmuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总局发布《保健食品注册与备案管理办法》</title>
    <updated>2020-11-03T19:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/jZIgv7n2BrVCsZCJlXmAZA</id>
    <link href="https://mp.weixin.qq.com/s/jZIgv7n2BrVCsZCJlXmAZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗开发与评价：抗体滴度与中和性抗体滴度检测</title>
    <updated>2020-11-03T19:56:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/tQvClDUuSgVuWeclh8GzGg</id>
    <link href="https://mp.weixin.qq.com/s/tQvClDUuSgVuWeclh8GzGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（43）-肝素诱导的血小板减少症</title>
    <updated>2020-11-02T19:26:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/ttbxp-Ed9jGD8TSY-M1ZMA</id>
    <link href="https://mp.weixin.qq.com/s/ttbxp-Ed9jGD8TSY-M1ZMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品生产监督检查应重点关注这五个方面！</title>
    <updated>2020-11-02T19:26:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/rfwmoBMBU8e2sFL0W0etTQ</id>
    <link href="https://mp.weixin.qq.com/s/rfwmoBMBU8e2sFL0W0etTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020版《中国药典》执行标准需要确认；工艺等变化的进行充分研究和验证！</title>
    <updated>2020-11-02T19:26:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/_ToFr_5o3wCKlPL91ADDTg</id>
    <link href="https://mp.weixin.qq.com/s/_ToFr_5o3wCKlPL91ADDTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国参比制剂发展简史及参比制剂申报受理</title>
    <updated>2020-11-02T19:26:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/ACQeBw2682a3MzynYy_eiQ</id>
    <link href="https://mp.weixin.qq.com/s/ACQeBw2682a3MzynYy_eiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020版CSCO非小细胞肺癌诊疗指南</title>
    <updated>2020-11-01T19:59:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/Cna0SJ2EoM0mY55YYULB0Q</id>
    <link href="https://mp.weixin.qq.com/s/Cna0SJ2EoM0mY55YYULB0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物杂质研究和分析方法开发（256张PPT）</title>
    <updated>2020-11-01T19:59:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/AVf4BTvPes83F4hB2nl4aw</id>
    <link href="https://mp.weixin.qq.com/s/AVf4BTvPes83F4hB2nl4aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国癌症年报出炉！全面了解早筛早诊、精准治疗和主动预防</title>
    <updated>2020-10-31T19:40:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/64I9JxfXHgR6p0AEIYEQ0Q</id>
    <link href="https://mp.weixin.qq.com/s/64I9JxfXHgR6p0AEIYEQ0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>探索我国罕见病患者药物可及的新途径: 疫情下的同情用药制度</title>
    <updated>2020-10-31T19:40:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/LiCrYeCYavBLZmx7_PIc5Q</id>
    <link href="https://mp.weixin.qq.com/s/LiCrYeCYavBLZmx7_PIc5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>